{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:45:56Z","timestamp":1777963556769,"version":"3.51.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,15]]},"DOI":"10.1097\/qai.0b013e31823801c4","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:46:03Z","timestamp":1317757563000},"page":"458-462","source":"Crossref","is-referenced-by-count":31,"title":["Control of Medical Comorbidities in Individuals With HIV"],"prefix":"10.1097","volume":"58","author":[{"given":"Anne K.","family":"Monroe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetanjali","family":"Chander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210131","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mjt.0000162013.66614.16","article-title":"Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Pathogenesis and Cardiovascular Risk.","volume":"13","author":"Barbaro","year":"2006","journal-title":"Am J Ther"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study.","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.20289","article-title":"Risk of diabetes in HIV infected veterans pre-and post-HAART and the role of HCV coinfection.","volume":"40","author":"Butt","year":"2004","journal-title":"Hepatology"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Womens Interagency HIV Study.","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10096-003-1034-z","article-title":"Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients.","volume":"22","author":"Bergersen","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/HJH.0b013e32830ef5fb","article-title":"Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.","volume":"26","author":"Baekken","year":"2008","journal-title":"J Hypertens"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.","volume":"15","author":"Bangsberg","year":"2001","journal-title":"AIDS"},{"issue":"suppl 1","key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/00042560-199801001-00011","article-title":"Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.","volume":"17","author":"Moore","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","article-title":"Antiretroviral therapy and management of HIV infection.","volume":"376","author":"Volberding","year":"2010","journal-title":"Lancet"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","article-title":"Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.","volume":"47","author":"Okonofua","year":"2006","journal-title":"Hypertension"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-148-8-200804150-00002","article-title":"Effect of unrelated comorbid conditions on hypertension management.","volume":"148","author":"Turner","year":"2008","journal-title":"Ann Intern Med"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/apc.2010.0237","article-title":"Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines.","volume":"25","author":"Satlin","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08998280.2007.11928265","article-title":"Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus.","volume":"20","author":"Bury","year":"2007","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R19-6-20210131","first-page":"159","article-title":"Cardiovascular risk and risk management in HIV-infected patients.","volume":"15","author":"Adeyemi","year":"2007","journal-title":"Top HIV Med"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients.","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0b013e3283365356","article-title":"Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.","volume":"24","author":"Neuhaus","year":"2010","journal-title":"AIDS"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11908-009-0036-0","article-title":"HIV infection in the elderly.","volume":"11","author":"Gebo","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/QAD.0b013e32831883f9","article-title":"Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.","volume":"22","author":"Greenbaum","year":"2008","journal-title":"AIDS"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research.","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication.","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2008.09.047","article-title":"Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.","volume":"122","author":"Cheung","year":"2009","journal-title":"Am J Med"},{"key":"R31-6-20210131","first-page":"31","article-title":"Persistence with treatment for hypertension in actual practice.","volume":"160","author":"Caro","year":"1999","journal-title":"Can Med Assoc J"},{"key":"R32-6-20210131","first-page":"71","article-title":"Oral antidiabetic medication adherence and glycemic control in managed care.","volume":"14","author":"Rozenfeld","year":"2008","journal-title":"Am J Manag Care"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1345\/aph.1D612","article-title":"Medication adherence and associated hemoglobin A1c in type 2 diabetes.","volume":"38","author":"Krapek","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18553\/jmcp.2006.12.3.239","article-title":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.","volume":"12","author":"Bramley","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1001\/jama.288.22.2880","article-title":"Helping patients follow prescribed treatment: clinical applications.","volume":"288","author":"Haynes","year":"2002","journal-title":"JAMA"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0895-4356(01)00450-4","article-title":"Patient-and provider-reported adherence toward a clinically useful approach to measuring antiretroviral adherence.","volume":"54","author":"Wagner","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R37-6-20210131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1525-1497.2002.11002.x","article-title":"Health-related quality of life in urban African Americans with type 2 diabetes.","volume":"17","author":"Hill-Briggs","year":"2002","journal-title":"J Gen Intern Med"},{"key":"R38-6-20210131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1037\/0278-6133.24.4.349","article-title":"Medication adherence and diabetes control in urban African Americans with type 2 diabetes.","volume":"24","author":"Hill-Briggs","year":"2005","journal-title":"Health Psychol"},{"issue":"suppl 5A","key":"R39-6-20210131","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/j.amjmed.2005.04.012","article-title":"Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.","volume":"118","author":"Rubin","year":"2005","journal-title":"Am J Med"},{"key":"R40-6-20210131","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc09-0177","article-title":"Hemoglobin A1c underestimates glycemia in HIV infection.","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care"},{"key":"R41-6-20210131","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-134-10-200105150-00011","article-title":"A comparison study of multiple measures of adherence to HIV protease inhibitors.","volume":"134","author":"Liu","year":"2001","journal-title":"Ann Intern Med"},{"key":"R43-6-20210131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/COH.0b013e3283311058","article-title":"Adherence to antiretroviral therapy: the more you look, the more you see.","volume":"4","author":"Taiwo","year":"2009","journal-title":"Curr Opin HIV AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201112150-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:52:52Z","timestamp":1618037572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201112150-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31823801c4","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}